Autres langues

01/06 Revium Rx. Announces CFO Changes, Effective May 27, 2026
14/05 Revium Rx. Reports Earnings Results for the First Quarter Ended March 31, 2026
20/04 Revium Rx. Appoints Amir Avraham as Permanent Chief Executive Officer, Effective as of February 1, 2026
20/04 Revium Rx. Appoints Shlomi Schwartzblat as Director and Chairman of the Board, Effective April 14, 2026
31/03 Revium Rx. Reports Earnings Results for the Full Year Ended December 31, 2025
31/03 Revium Rx. Auditor Raises 'Going Concern' Doubt
16/01 Revium Rx. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
21/10/25 Revium Rx Advances Toward Phase 1 Clinical Development of Nano-Mupirocin to Combat Antibiotic-Resistant Infections
21/10/25 Revium Recovery Inc. Advances Toward Phase 1 Clinical Development of Nano-Mupirocin to Combat Antibiotic-Resistant Infections
03/10/25 Revium Rx. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025
14/02/25 Revium Rx. has filed an IPO in the amount of $5 million.
04/02/25 Revium Rx (RVRC) Completes Acquisition of LipoVation Ltd.
04/02/25 Revium Recovery Inc. completed the acquisition of LipoVac, Ltd.
21/12/22 Revium Recovery, Inc. Announces Letter of Intent to Acquire LipoVac Ltd
20/12/22 Revium Recovery, Inc. Announces Letter of Intent to Acquire LipoVac Ltd.
20/12/22 Revium Recovery Inc. entered into a letter of intent to acquire LipoVac, Ltd.
07/01/21 Revium Recovery Inc. will Change its Ticker to RVRC from OCBG.D
17/12/20 Correction: REVIUM RECOVERY ACQUIRES ANTI-ADDICTION REHABILITATION BUSINESS
09/12/20 OC Beverages, Inc. has Changed its Name to Revium Recovery Inc
09/12/20 Revium Recovery Inc. has Changed its Ticker to OCBG.D from OCBG
Aucun résultat pour cette recherche
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT